Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
about
Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.Clarithromycin in treatment of early Lyme disease: a pilot studyAntimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.
P2860
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@en
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@nl
type
label
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@en
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@nl
prefLabel
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@en
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@nl
P2093
P2860
P356
P1476
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
@en
P2093
P2860
P304
P356
10.1128/AAC.37.6.1329
P407
P577
1993-06-01T00:00:00Z